4-((4-Methylpiperazin-1-yl)methyl)aniline → HCID 70685609, compound
Reaction equation
Cl[C:2]1[N:7]=[C:6]([C:8]2[CH:13]=[CH:12][C:11]([F:14])=[CH:10][C:9]=2[S:15]([N:18]([CH3:20])[CH3:19])(=[O:17])=[O:16])[C:5]([Cl:21])=[CH:4][N:3]=1.[CH3:22][N:23]1[CH2:28][CH2:27][N:26]([CH2:29][C:30]2[CH:36]=[CH:35][C:33]([NH2:34])=[CH:32][CH:31]=2)[CH2:25][CH2:24]1>C(Cl)Cl.CO>[Cl:21][C:5]1[C:6]([C:8]2[CH:13]=[CH:12][C:11]([F:14])=[CH:10][C:9]=2[S:15]([N:18]([CH3:20])[CH3:19])(=[O:17])=[O:16])=[N:7][C:2]([NH:34][C:33]2[CH:32]=[CH:31][C:30]([CH2:29][N:26]3[CH2:25][CH2:24][N:23]([CH3:22])[CH2:28][CH2:27]3)=[CH:36][CH:35]=2)=[N:3][CH:4]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound was prepared according to synthesis procedure B described above from 2-(2,5-dichloropyrimidin-4-yl)-5-fluoro-N,N-dimethylbenzenesulfonamide and 4-((4-methylpiperazin-1-yl)methyl)aniline in 44% yield (yellow solid) after flash chromatography (CH2Cl2/CH3OH 99:1 gradually increasing to 95:5). 1H NMR (400 MHz, CDCl3): δ 8.39 (m, 2H), 8.08 (m, 1H), 7.48 (d, 2H, J=8.4 Hz), 7.30-7.20 (m, 4H), 3.41 (s, 2H), 2.82 (s, 6H), 2.40 (bs, 8H), 2.22 (s, 3H); MS (ESI): 519.2 [M+H]+.
Workup
- customaccording to synthesis procedure B
- temperaturegradually increasing to 95:5)
Sources & evidence
- ORD record
- ord-f8fbfabb5b9d4950a73b7bc9e1cae43c
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08901120B2
Reaction notes
Loading…